Hearing Loss, Sensorineural Clinical Trial
— EOSPOfficial title:
Evaluation of an Open-source Speech-processing Platform
NCT number | NCT03686046 |
Other study ID # | 58786 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 10, 2019 |
Est. completion date | July 31, 2021 |
Determining acceptability and usability of a wearable open-source speech processing platform (Master Hearing Aid) developed for hearing-aid research
Status | Recruiting |
Enrollment | 30 |
Est. completion date | July 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Sensorineural hearing loss Exclusion Criteria: - Cognitively challenged - Legally blind |
Country | Name | City | State |
---|---|---|---|
United States | San Diego State University, Audiology Clinic | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
San Diego State University | University of California, San Diego |
United States,
Boothroyd A, Mackersie C. A "Goldilocks" Approach to Hearing-Aid Self-Fitting: User Interactions. Am J Audiol. 2017 Oct 12;26(3S):430-435. doi: 10.1044/2017_AJA-16-0125. — View Citation
Boothroyd A. The performance/intensity function: an underused resource. Ear Hear. 2008 Aug;29(4):479-91. doi: 10.1097/AUD.0b013e318174f067. — View Citation
Lee CH, Kates JM, Rao BD, Garudadri H. Speech quality and stable gain trade-offs in adaptive feedback cancellation for hearing aids. J Acoust Soc Am. 2017 Oct;142(4):EL388. doi: 10.1121/1.5007278. — View Citation
Mackersie C, Boothroyd A, Lithgow A. A "Goldilocks" Approach to Hearing Aid Self-Fitting: Ear-Canal Output and Speech Intelligibility Index. Ear Hear. 2019 Jan/Feb;40(1):107-115. doi: 10.1097/AUD.0000000000000617. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Response to structured interview | A wearable speech-processing platform for hearing-aid research How long might you be prepared to wear this device as a hearing aid for purposes of research? How do you rate the appearance and wearability of the device? How do you rate the performance of the device as a hearing aid? What changes might increase your willingness to wear this device for research purposes? What changes might increase your rating of appearance? What changes might increase your rating of performance? |
Approximately 2 weeks after last participant completes the exploratory use, estimated to be about 6 months. | |
Secondary | Electro-acoustic performance of the speech-processing platform | Real-ear gain versus frequency curves of the speech-processing platform, before and after self-adjustment during the brief trial, will be obtained with the Verifit 2 hearing-aid test system - using standard audiological clinical procedures. (Mackersie, Boothroyd and Lithgow, 2018). | Approximately 2 weeks after last participant completes the exploratory use, estimated to be about 6 months. | |
Secondary | Aided speech perception | Participants will repeat prerecorded single syllable words presented at varying levels levels from a loudspeaker. Performance will be assessed as the percentage of speech sounds correctly repeated and will be measured while wearing the speech-processing platform as set before and after self-adjustment. (Boothroyd, 2008) | Approximately 2 weeks after last participant completes the exploratory use, estimated to be about 6 months. | |
Secondary | Pattern of user self-adjustments. | Changes of gain and spectral slope initiated by participants in response to changing , estimated to be about 6 months.acoustic conditions will be automatically logged by the self-adjustment software. (Boothroyd and Mackersie (2017) | Approximately 2 weeks after last participant completes the exploratory use | |
Secondary | Participant-specified issues, comments, and opinions | Focus group for all participants | Approximately 2 months after last participant completes the exploratory use, estimated to be about 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04281953 -
Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
|
||
Not yet recruiting |
NCT05973669 -
MED-EL Remote Care Multi-Center Feasibility Study
|
N/A | |
Completed |
NCT04601909 -
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
|
Phase 1 | |
Active, not recruiting |
NCT04479761 -
Sensory Integration of Auditory and Visual Cues in Diverse Contexts
|
N/A | |
Recruiting |
NCT05043207 -
A Study Protocol for the Validation of UAud in a Clinical Setting.
|
N/A | |
Recruiting |
NCT04070937 -
Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
|
||
Recruiting |
NCT04066270 -
Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
|
||
Completed |
NCT03512951 -
Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception
|
N/A | |
Completed |
NCT05855005 -
Direct-to-Consumer Hearing Aids and Listening Effort
|
N/A | |
Recruiting |
NCT05599165 -
Speech Perception in Bimodal Hearing
|
N/A | |
Completed |
NCT05101083 -
Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids
|
N/A | |
Completed |
NCT05521308 -
Investigating Hearing Aid Frequency Response Curves
|
N/A | |
Completed |
NCT05072457 -
Benefit of Assistive Listening Device for Lateralization
|
N/A | |
Recruiting |
NCT05776459 -
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
|
Phase 2 | |
Completed |
NCT05086276 -
FX-322 in Adults With Acquired Sensorineural Hearing Loss
|
Phase 2 | |
Recruiting |
NCT06058767 -
Preschool Hearing Screening
|
N/A | |
Completed |
NCT05180630 -
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
|
N/A | |
Completed |
NCT03613909 -
Acceptance of the CP950 Sound Processor
|
N/A | |
Active, not recruiting |
NCT03352154 -
Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants
|
N/A | |
Completed |
NCT04629664 -
FX-322 in Adults With Severe Sensorineural Hearing Loss
|
Phase 1 |